AI, biomarkers, and novel oncology modalities are driving evolution in biopharma pipelines, according to Nmblr CEO Janice MacLennan.
Janice MacLennan
Advertisement
Janice MacLennan is a senior strategy consultant to Big Pharma and the founder and CEO of Nmblr.
Articles by Janice MacLennan
Janice MacLennan, CEO of Nmblr, notes how AI is transforming biopharma R&D and market access, forcing teams to prove value beyond science and redesign work around human strengths.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
4
Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity
5